HEPATITIS C

Empowering People to be Ambassadors of their Own Health Since 1997.

Monthly Pubmed Review

Monthly Pubmed Review of the Most Relevant Research on Hepatitis C
Literature Review, April 2014

CLINICAL TRIALS, COHORT STUDIES, PILOT STUDIES

BASIC AND APPLIED SCIENCE, PRE-CLINICAL STUDIES

HIV/HCV COINFECTION

COMPLEMENTARY AND ALTERNATIVE MEDICINE

Medicinal plants against hepatitis C virus.                 http://www.ncbi.nlm.nih.gov/pubmed/24659884

Antiviral activity of extracts from Morinda citrifolia leaves and chlorophyll catabolites, pheophorbide a and pyropheophorbide a, against hepatitis C virus. http://www.ncbi.nlm.nih.gov/pubmed/24438164

Anti-hepatitis C virus compounds obtained from Glycyrrhiza uralensis and other Glycyrrhiza species.                                                      http://www.ncbi.nlm.nih.gov/pubmed/24397541

EPIDEMIOLOGY, DIAGNOSTICS, AND MISCELLANEOUS WORKS

Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virus.

 

Hepatitis C virus infection in end stage renal disease and kidney transplantation.

 

Multiplex Microfluidic Paper-based Immunoassay for the Diagnosis of Hepatitis C Virus Infection

 

Statins and Hepatitis C Virus Infection: An Old Therapy With New Scope.

 

Response-Guided Therapy in Patients with Genotype 1 HCV: Current Status and Future Prospects.

 

Cellular fibronectin expression in chronic hepatitis C virus patients.

 

Bridging Basic Science and Clinical Research – The EASL Monothematic Conference on Translational Research in Viral Hepatitis.

Inpatient resource utilization, disease severity, mortality and insurance coverage for patients hospitalized for hepatitis C virus in the United States.

 

Expanding primary care capacity to treat hepatitis C virus infection through an evidence-based care model – Arizona and utah, 2012-2014.

 

Hepatitis C Virus-Related Knowledge and Willingness to Receive Treatment Among Patients on Methadone Maintenance.

 

Reliable prediction of clinical outcome in patients with chronic HCV infection and compensated advanced hepatic fibrosis: a validated model using objective and readily available clinical parameters.

 

Elevated plasma sphingomyelin (d18:1/22:0) is closely related to hepatic steatosis in patients with chronic hepatitis C virus infection.

 

Transfusion-associated hepatitis before the screening of blood for hepatitis risk factors.

 

The hepatitis C cascade of care: identifying priorities to improve clinical outcomes.

 

Hepatitis C disease burden and strategies to manage the burden (Guest Editors Mark Thursz, Gregory Dore and John Ward).

LIVER CANCER

Caring Ambassadors Program, Inc. | P.O. Box 1748 | Oregon City, OR 97045 | 503-632-9032 | 503-632-9038 (Fax)